首页> 外国专利> Use of anastrozole or a pharmaceutically acceptable salt thereof, and methods for reducing the recurrence rate of cancer and the rate of a new contralateral primary tumor in a postmenopausal woman having early breast cancer.

Use of anastrozole or a pharmaceutically acceptable salt thereof, and methods for reducing the recurrence rate of cancer and the rate of a new contralateral primary tumor in a postmenopausal woman having early breast cancer.

机译:阿那曲唑或其药学上可接受的盐的用途,以及在患有早期乳腺癌的绝经后妇女中降低癌症的复发率和新的对侧原发肿瘤率的方法。

摘要

"USE OF ANASTROZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND METHODS TO REDUCE THE CANCER RECURRENCE RATE AND RATE OF A NEW CONTRALATERAL TUMOR IN A POST-MENOPAUS WOMAN HAVING INCANIAL CANCER." The invention provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for reducing cancer recurrence rate in a woman having early breast cancer. The invention further provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for reducing the rate of a new contralateral primary tumor in a postmenopausal woman having early breast cancer.
机译:“使用纳那曲唑或其药用盐,以及降低患有癌性绝经后妇女的癌后复发率和新对侧肿瘤的发生率的方法。”本发明提供了阿那曲唑或其药学上可接受的盐在制备用于降低患有早期乳腺癌的妇女的癌症复发率的药物中的用途。本发明进一步提供了阿那曲唑或其药学上可接受的盐在制备用于降低患有早期乳腺癌的绝经后妇女中新的对侧原发性肿瘤的比率的药物中的用途。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号